# LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
> **NDA022344** · New Drug Application · Sponsor: AUROBINDO PHARMA LTD · Approved 2018-05-15
## Drug
- **FDA Application Number:** NDA022344
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** AUROBINDO PHARMA LTD
- **First approval:** 2018-05-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022344)
---
*AI Analytics · CC0 1.0*